Concepedia

Alan Nicholas

AN

20

Publications

2.6K

Citations

16

H-Index

2017

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Dana-Farber Cancer Institute

Moffitt Cancer Center

University of California, Los Angeles

City of Hope

Alan Nicholas is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

2017–2024

20

Publications

20

Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma

Ann‐Lii Cheng, Shukui Qin, Masafumi Ikeda et al. · Journal of Hepatology · 2021 · 1.5K citations · Full text

, , +9

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial

Jamie E. Chaft, Filiz Öezkan, Mark G. Kris et al. · Nature Medicine · 2022 · 222 citations · Full text

Developmental change in the influence of domain-general abilities and domain-specific knowledge on mathematics achievement: An eight-year longitudinal study.

David C. Geary, Alan Nicholas, Yaoran Li et al. · Journal of Educational Psychology · 2017 · 176 citations · Full text

Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).

David J. Kwiatkowski, Valerie W. Rusch, Jamie E. Chaft et al. · Journal of Clinical Oncology · 2019 · 146 citations

, , +18

Pertuzumab Plus High-Dose Trastuzumab in Patients With Progressive Brain Metastases and HER2-Positive Metastatic Breast Cancer: Primary Analysis of a Phase II Study

Nancy U. Lin, Mark D. Pegram, Solmaz Sahebjam et al. · Journal of Clinical Oncology · 2021 · 92 citations · Full text

Rows per page

1–5 of 20